Bharat Immunological & Biological Corporation Ltd Net Loss is INR -1.89 crores in Quarter 3, October – December of Financial Year 2020-2021.
Quarterly Net Earnings Year-on-Year
Bharat Immunological & Biological Corporation Ltd Quarter Net Loss is widen by -20 % from Last Year Quarter and Net Loss of INR -1.89 crores is reported in Quarter 3, October – December of Financial Year 2020-2021. Last Year Quarter 3, October – December of Financial Year 2019-2020sa Net Loss was INR -2.35 crores.
Quarterly Net Sales Year-on-Year
Bharat Immunological & Biological Corporation Ltd Quarter Sale is down -12 % from Last Year Quarter.
Annual Sales & Net Earning
Bharat Immunological & Biological Corporation Ltd Annual Sales in Financial Year 2019 to 2020 was reported INR 83.65 crores and Annual Profit in Financial Year 2019 to 2020 was reported INR -5.79 crores.
Bharat Immunological & Biological Corporation Ltd Stock Information
| Sector | Pharmaceuticals |
| Industry | Pharmaceuticals – Indian – Formulations |
| About | Bharat Immunologicals and Biologicals Corporation is an India-based biotechnology company. The Company manufactures and produces a range of pharmaceuticals products, such as Oral Polio Vaccines (OPV Vaccine), Zinc Tablet and Diarrhea Management Kit (Zinc Tablet + oral rehydration salts (ORS)). |
| Latest Qaurter EPS | -0.4376964967437682 |
Bharat Immunological & Biological Corporation Ltd Stock Analysis:
Get more Quarterly Earnings Results of companies
Get complete data on Bharat Immunological & Biological Corporation Ltd
